BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 14586135)

  • 1. IGF-1 induces growth, survival and morphological change of primary hepatocytes on a galactose-bared polymer through both MAPK and beta-catenin pathways.
    Kundu AK; Nagaoka M; Chowdhury EH; Hirose S; Sasagawa T; Akaike T
    Cell Struct Funct; 2003 Aug; 28(4):255-63. PubMed ID: 14586135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IGFs stimulate zebrafish cell proliferation by activating MAP kinase and PI3-kinase-signaling pathways.
    Pozios KC; Ding J; Degger B; Upton Z; Duan C
    Am J Physiol Regul Integr Comp Physiol; 2001 Apr; 280(4):R1230-9. PubMed ID: 11247849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of insulin-like growth factor (IGF) binding protein-3 synthesis by IGF-I and transforming growth factor-alpha is mediated by both phosphatidylinositol-3 kinase and mitogen-activated protein kinase pathways in mammary epithelial cells.
    Sivaprasad U; Fleming J; Verma PS; Hogan KA; Desury G; Cohick WS
    Endocrinology; 2004 Sep; 145(9):4213-21. PubMed ID: 15192040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor-I-dependent signal transduction pathways leading to the induction of cell growth and differentiation of human neuroblastoma cell line SH-SY5Y: the roles of MAP kinase pathway and PI 3-kinase pathway.
    Kurihara S; Hakuno F; Takahashi S
    Endocr J; 2000 Dec; 47(6):739-51. PubMed ID: 11228049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways in stimulation of vascular smooth muscle cell migration and deoxyriboncleic acid synthesis by insulin-like growth factor-I.
    Imai Y; Clemmons DR
    Endocrinology; 1999 Sep; 140(9):4228-35. PubMed ID: 10465296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LY 294002, an inhibitor of phosphatidylinositol 3-kinase, inhibits GH-mediated expression of the IGF-I gene in rat hepatocytes.
    Shoba LN; Newman M; Liu W; Lowe WL
    Endocrinology; 2001 Sep; 142(9):3980-6. PubMed ID: 11517177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional evaluation of poly-(N-p-vinylbenzyl-O-beta-D-galactopyranosyl-[1-4]-D-gluconamide)(PVLA) as a liver specific carrier.
    Watanabe Y; Liu X; Shibuya I; Akaike T
    J Biomater Sci Polym Ed; 2000; 11(8):833-48. PubMed ID: 11211095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple signaling pathways mediate interleukin-4-induced 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase type 1 gene expression in human breast cancer cells.
    Gingras S; Côté S; Simard J
    Mol Endocrinol; 2000 Feb; 14(2):229-40. PubMed ID: 10674396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low asialoglycoprotein receptor expression as markers for highly proliferative potential hepatocytes.
    Ise H; Sugihara N; Negishi N; Nikaido T; Akaike T
    Biochem Biophys Res Commun; 2001 Jul; 285(2):172-82. PubMed ID: 11444822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of urokinase-type plasminogen activator by insulin-like growth factor-I depends upon phosphatidylinositol-3 kinase and mitogen-activated protein kinase kinase.
    Dunn SE; Torres JV; Oh JS; Cykert DM; Barrett JC
    Cancer Res; 2001 Feb; 61(4):1367-74. PubMed ID: 11245436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural effect of galactose residue in synthetic glycoconjugates on interaction with rat hepatocytes.
    Yura H; Goto M; Okazaki H; Kobayashi K; Akaike T
    J Biomed Mater Res; 1995 Dec; 29(12):1557-65. PubMed ID: 8600146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor-1 induces survival and growth of biologically early melanoma cells through both the mitogen-activated protein kinase and beta-catenin pathways.
    Satyamoorthy K; Li G; Vaidya B; Patel D; Herlyn M
    Cancer Res; 2001 Oct; 61(19):7318-24. PubMed ID: 11585772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential regulation of the phosphoinositide 3-kinase and MAP kinase pathways by hepatocyte growth factor vs. insulin-like growth factor-I in myogenic cells.
    Halevy O; Cantley LC
    Exp Cell Res; 2004 Jul; 297(1):224-34. PubMed ID: 15194438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor I induces proliferation and migration of porcine trophectoderm cells through multiple cell signaling pathways, including protooncogenic protein kinase 1 and mitogen-activated protein kinase.
    Jeong W; Song G; Bazer FW; Kim J
    Mol Cell Endocrinol; 2014 Mar; 384(1-2):175-84. PubMed ID: 24508636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anchorage-independent activation of mitogen-activated protein kinase through phosphatidylinositol-3 kinase by insulin-like growth factor I.
    Suzuki K; Takahashi K
    Biochem Biophys Res Commun; 2000 May; 272(1):111-5. PubMed ID: 10872812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor-I inhibits cell growth in the a549 non-small lung cancer cell line.
    Kodama Y; Baxter RC; Martin JL
    Am J Respir Cell Mol Biol; 2002 Sep; 27(3):336-44. PubMed ID: 12204896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor signaling pathways in rat hepatic stellate cells: importance for deoxyribonucleic acid synthesis and hepatocyte growth factor production.
    Skrtic S; Wallenius K; Gressner AM; Jansson JO
    Endocrinology; 1999 Dec; 140(12):5729-35. PubMed ID: 10579338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of MAP kinase activity moderates changes in expression and function of Cx32 but not claudin-1 during DNA synthesis in primary cultures of rat hepatocytes.
    Kojima T; Yamamoto T; Lan M; Murata M; Takano K; Go M; Ichimiya S; Chiba H; Sawada N
    Med Electron Microsc; 2004 Jun; 37(2):101-13. PubMed ID: 15221652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor I-mediated protection from rapamycin-induced apoptosis is independent of Ras-Erk1-Erk2 and phosphatidylinositol 3'-kinase-Akt signaling pathways.
    Thimmaiah KN; Easton J; Huang S; Veverka KA; Germain GS; Harwood FC; Houghton PJ
    Cancer Res; 2003 Jan; 63(2):364-74. PubMed ID: 12543789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of ligand orientation on hepatocyte attachment onto the poly(N-p-vinylbenzyl-o-beta-D-galactopyranosyl-D-gluconamide) as a model ligand of asialoglycoprotein.
    Cho CS; Goto M; Kobayashi A; Kobayashi K; Akaike T
    J Biomater Sci Polym Ed; 1996; 7(12):1097-104. PubMed ID: 8880441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.